Hasil Pencarian (1)
small molecule | CAS: 158966-92-8
Montelukast was first approved for clinical use by the US FDA in 1998 as Merck's brand name Singulair.[L6301] The medication is a member of the leukotriene receptor antagonist (LTRA) category of drugs.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Although capab…
Kategori:
Acids, AcyclicAgents Causing Muscle ToxicityAgents to Treat Airway Disease
+29
Target Protein:
Cysteinyl leukotriene receptor 1Polyunsaturated fatty acid 5-lipoxygenase
Waktu ParuhStudies have demons…
Vol. DistribusiThe steady-state vo…
KlirensThe plasma clearanc…
Genetik
-